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Abstract
Background: Small for gestational age (SGA) infants are at increased risk for preterm birth morbidities as well as a
range of adverse perinatal outcomes that result in part from associated premature birth. We sought to evaluate the
costs of SGA versus appropriate for gestational age (AGA) infants in France from pregnancy through the first year of
life and separate the contributions of prematurity from the contribution of foetal growth on costs.
Methods: This is a cross-sectional population-based study using national hospital discharge data from French
public and private hospitals. SGA infants were defined as newborns with a birth weight below the 10th percentile
of French intrauterine growth curves adjusted for foetal sex. AGA infants were defined as newborns with a birth
weight between the 25th and the 75th. All births were selected between January 1st, 2011 and December 31st,
2011. Costs were calculated from the hospital perspective for both mothers and children using their diagnostic
related group and the French national cost study. Hospital outcomes were extracted from the database and
compared by gestational age and mode of delivery.
Results: Of 777,720 total births in 2011, 84,688 SGA births (10.9%) and 395,760 AGA births (50.8%) were identified.
After adjustment for gestational age, the cost for an SGA infant was €2,783 higher than for an AGA infant. The total
maternal and infant hospital cost of SGA in France was estimated at 23% the total cost for deliveries. The high cost
is explained by higher complication rates, more frequent hospital readmissions and longer lengths of stay.
Conclusions: Being small for gestational age is an independent contributor to 1-year hospital costs for both
mothers and infants.
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Background
Small for gestational age (SGA) infants are defined by a
birth weight lower than the 10th percentile for a given
gestational age. SGA infants are at increased risk for pre-
term birth morbidities as well as a range of adverse peri-
natal outcomes that result in part from associated
premature birth. In adulthood, conditions such as meta-
bolic syndrome, diabetes and hypertension develop more
often in individuals born SGA regardless of whether the
birth was preterm. Although the health sequelae of SGA
are well-documented, relatively little is known about
their economic consequences either in early or later life
[1]. Morbidity and mortality related to SGA creates a
burden for both families and the health care system.
Several national and international studies have ad-
dressed the cost of preterm birth; however, few have es-
timated the cost of SGA separately from the cost of
prematurity [2–6]. A Canadian study suggested that
gestational age was a better predictor of cost than fetal
growth: premature SGA babies cost at birth was
$109,286 versus $85,103 for premature non-SGA ba-
bies, while the average cost of full term SGA baby was
about twice the cost of a full term non-SGA baby [2].
The intricacy of the relationship between prematurity
and SGA contributes to the difficulty of distinguishing
those two pathologies in the current literature [3, 4, 7].
Such a distinction, however, would allow better assess-
ment of the medical and economic consequences of SGA
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during the neonatal period, childhood and throughout life
and help to focus research priorities on early identification
of at-risk foetuses.
Our objective was to estimate the additional hospital
cost associated with SGA infants from pregnancy
through the first year of life and to separate the contri-
butions of prematurity from the contribution of SGA on
costs.
Methods
We used data from the 2011 and 2012 French national
hospital claims database (Programme de Médicalisation
des Systèmes d’Information; PMSI), which collects linked,
anonymised medical records of all French inpatient and
day case admissions in both public and private hospitals.
Maternal and newborn records are linked at the national
level. Such administrative databases have been previ-
ously used to estimate costs and outcomes of preterm
infants [4, 8, 9].
Population
We extracted the records of all infants born in metro-
politan France in public and private hospitals from
January 1, 2011 to December 31, 2011. Hospitalisations
during the first year of life were identified by record
linkage. Selection of the population was based on the
Diagnostic Related Group (DRG), weight and gesta-
tional age in addition to diagnoses, procedures and ad-
ministrative information.
Exclusion criteria were multiple pregnancies, stillbirths
(because postnatal costs would be non-existent), prob-
lems in the anonymisation process, unclassifiable DRGs,
congenital or chromosomal abnormality and absence of
data about the weight, sex and gestational age.
We defined subgroups by gestational age (in com-
pleted weeks): [22–28[ (from 22 to 28 not included),
[28–32[, [32–37[, [37–39[ and [39–43[. Births before
37 weeks were considered preterm. Within each class of
gestational age we classified newborns into SGA and
AGA. SGA infants were defined as having birthweights
below the 10th percentile of the French intrauterine
growth curve adjusted for foetal sex. [10] AGA infants
were defined as having birthweights between the 25th
and the 75th percentiles of the same growth curve. We
chose this definition for the control group in order to re-
duce the variability in practice patterns and costs that
would occur in the range approaching pathological con-
ditions. These reference curves were recently developed
using the representative sample of births from the
French Perinatal Survey (FPS) 2010. Initially proposed
by Gardosi in the 1990s, they are based on a modelisa-
tion of intrauterine growth and foetal weight. SGA
thresholds are individually defined according to foetal
and maternal physiological factors influencing growth.
This definition of SGA births is currently supported by
several international guidelines for screening and man-
agement of SGA births. Due to a lack of data about ma-
ternal height, weight and parity in the French hospital
discharge database, we applied the model adjusted for
foetal sex. [10–12] Mothers were identified in the data-
base by linkage to the newborn hospital records. Data
analysis was authorized by the French data protection
authority (CNIL authorization number: 1606292 v 1).
Outcomes
Type of delivery and complications were identified by
the International Classification of Diseases, tenth revi-
sion (ICD-10) and procedures codes. Mortality was de-
fined as death during the index hospitalisation or during
the first year of life and excluded stillbirths. Deaths were
identified using the discharge status; in-hospital death
during the first year was identified by record linkage.
The mortality information provided by DRGs was veri-
fied via a national standard procedure with linkage to
national death registries [13–15].
Hospital resources and costs
A summary of all hospital inpatient service utilisation
from the day of birth through the first year of life was
compiled for all study infants. Record linkage between
newborns and mothers was used to identify hospital ad-
missions during pregnancy and delivery-related costs.
Data extracted included mode of delivery and type of
neonatology unit, date of each admission, length of stay,
procedures performed and ICD-10 codes. The total time
infants and mothers spent in the hospital was calculated
by summing the lengths of stay of successive admissions
(including day cases) over a 1-year period. Hospital costs
were calculated from the health insurance perspective
[16]. Ambulatory expenses are not included in the dis-
charge database. The total cost of deliveries in France
and the SGA share of this cost was also estimated. All
costs are in 2015 €.
Statistical analysis
Maternal and neonatal characteristics, resource utilisa-
tion (length of stay, use of intensive care, readmission)
and costs were summarised by gestational age and com-
pared between SGA and AGA infants using Pearson’s
Chi-squared test and Wilcoxon’s test for qualitative and
quantitative variables respectively. All tests were two-
sided, and p-values lower than 0.05 were considered
statistically significant. Determinants of cost variations
between the two groups were studied according to gesta-
tional age. Results are presented in means and standard
deviations (SD); because of the skewed distribution of
costs we also reported medians and interquartile ranges
(IQR). The excess mortality was calculated by dividing
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the mortality rate of the SGA group by the mortality rate
of the AGA group in each gestational age class. Cost dif-
ferences and their standard deviations were calculated
using 1,000 bootstrap replications. All analyses were per-
formed with SAS version 9.3 (SAS Institute, Cary, NC).
Results
Population
A total of 777,720 births and 858,608 admissions were
identified nationally We excluded N = 59,082 linked ad-
missions, N = 13,106 multiple pregnancies, N = 4,873 un-
classifiable DRGs, N = 1,354 congenital or chromosomal
abnormalities, N = 2,473 missing values for weight and
gestational age, N = 180,978 non-SGA or -AGA births,
N = 6,828 stays with problems in mother-infant record
linkage and N = 3,660 stillbirths (Fig. 1). After applying
the exclusion criteria, 84,688 SGA births (10.9% of total
births) and 395,760 AGA births (51.8% of total births)
remained for the analyses. There were 3,660 stillbirths,
2,069 in the SGA group (1.8% of total SGA births) ver-
sus 1,591 in the AGA group (0.3% of total AGA births).
Population characteristics are presented in Table 1.
Preterm birth was reported for 11,097 individuals
(13.1%) in the SGA group and 22,627 individuals (5.7%)
in the AGA group (gestational age < 37 weeks). The
average age of mothers was 28.9 (SD = 5.9) years in the
SGA group and 29.1 (SD = 5.7) years in the AGA group
(p < 0.001). The proportion of deliveries in public hospi-
tals was higher in the SGA group (64,117 births, 75.7%
versus 282,180 births, 71.3%).
Outcomes
Caesarean section delivery was performed for 17.8% of
the SGA mothers versus 13.5% of the AGA mothers.
The rate of caesarean section was consistently higher in
SGA versus AGA births for all gestational ages, with the
Fig. 1 Selection of the study population
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highest excess rate in the [28–32[ weeks gestational age
group and lowest in the [37–39] weeks gestational age
group (Table 2).
Mortality during the first year of life was higher in
SGA infants with 529 deaths (0.60%) versus 628 deaths
(0.16%) in AGA, p < 0.001. Mortality was highest in the
[22–28[ weeks gestational age group (Table 3) regardless
of birth weight. After stratification by gestational age, we
found that the excess mortality of SGA was the lowest
between 22 and 28 weeks of gestation and increased
twofold after 37 weeks (Fig. 2).
Hospital resources and costs
Mothers
Hospital admission during the prenatal period occurred
in 23.6% mothers in the SGA group versus 19.6% in the
AGA group. The average length of prenatal stay was 2.3
(SD = 5.9, median = 0 and IQR = [0;2]) days in the SGA
group versus 1.8 (SD = 5.3, median = 0 and IQR = [0;1])
days in the AGA group (p < 0.001). The average length
of post-partum hospitalisation was higher in the SGA
group, 5.9 (SD = 4.7, median = 5 and IQR = [4;6]) days
versus 4.9 (SD = 3.4, median = 4 and IQR = [4;5]) days
(p < 0.001).
The average pregnancy hospital costs were €868 (SD
= €1,975, median = €0 and IQR = [€0; €932]) and €655
(SD = €1,736, median = €0 and IQR = [€0; €746]) in the
SGA and AGA groups respectively for all mothers. The
average delivery costs were €2,563 (SD = €1,443,
median = €2,418 and IQR = [€2,033; €2,806]) and €2,357
(SD = €917, median = €2,076 and IQR = [€2,033; €2,418])
in the SGA and AGA groups respectively. The total aver-
age pre- and post-natal cost for mothers was higher in the
SGA group €3,431 (SD = €2,637; median = €2,689 and
IQR = [€2,123–€3,738]) versus €3,012 (SD = €2,138; me-
dian = €2,418; IQR = [€2,033–€3,127]) in the AGA group
(p < 0.001). After stratifying by gestational age, the average
total cost was higher in the SGA than in the AGA infants
in all age groups (Table 4).
Infants
The 84,688 SGA births had 1.3 hospital admissions/in-
fant during the first year, with a readmission rate of
16.4%, while the 395,760 AGA births had 1.2 admission/
infant and a 12.9% readmission rate. There were also
more emergency hospital transfers in the SGA group
than in the AGA group (8 vs. 3.6%) and a higher propor-
tion of infants transferred to intensive care during the
initial or subsequent admissions (22.5% versus 8.3%, p <
0.001). The excess transfer and readmission rate was
greater for SGA infants with preterm birth (31.3% versus
25.3% in preterm AGA, p < 0.001) than for full term
births (14.2% versus 12.2% for term AGA, p < 0.001).
The average length of stay for the initial hospitalisation
was 7 days (median = 4 and IQR = [4;6]) in the SGA
group versus 4.6 days (median = 4 and IQR = [3;5]) in
the AGA group (p < 0.001) with an average length of stay
in intensive care of 3.4 days (median = 0 and IQR = [0;0])
versus 0.7 day (median = 0 and IQR = [0;0]) (p < 0.001).
The average total length of stay during the first year was
7.8 days (median = 3 and IQR = [2;7]) versus 5.1 days
(median = 3 and IQR = [2;6]), (p < 0.001).
Table 1 Characteristics of the population at birth in small and







N % N % RR [CI 95%]
Sex
Male 42,646 50.36 200,653 50.70
Female 42,042 49.64 195,107 49.30 0.99 [0.97; 1.01]
Gestational age
<37 weeks 11,097 13.10 22,627 5.72 0.53 [0.52; 0.53]
Delivery
Caesarean 15,074 17.8 53,428 13.5
Vaginal delivery 69,614 82.2 342,332 86.5 1.39 [1.35; 1.41]
ICU admission
YES 18,320 21.63 28,485 7.20 0.31 [0.31; 0.32]
ICU Intensive Care Unit; SGA Small for Gestational Age;
AGA Appropriate for Gestational Age
Table 2 Type of delivery section according to gestational age in SGA and AGA infants
SGA delivery AGA Delivery Risk Ratio for
caesarean section
AGA/SGA
Caesarean Vaginal delivery Caesarean Vaginal delivery RR [95% CI]
Gestational age (weeks) [22–28[ (N = 1,213) 34.0% 66.0% 22.6% 77.4% 1.75 [1.37; 2.27]
[28–32[ (N = 3,346) 46.7% 53.3% 29.7% 70.3% 2.08 [1.79; 2.44]
[32–37[ (N = 29,165) 35.3% 64.7% 17.9% 82.1% 2.5 [2.38; 2.63]
[37–39[ (N = 101,974) 19.9% 80.1% 15.9% 84.1% 1.32 [1.27; 1.37]
[39–43[ (N = 344,750) 14.8% 85.2% 12.1% 87.9% 1.25 [1.22; 1.28]
SGA Small for Gestational Age; AGA Appropriate for Gestational Age
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The average cost of the initial hospitalisation was
€2,948 (SD = €7,292; median = €903; IQR = [€903;
€1,699]) in the SGA group and €1,328 (SD = €3,053;
median = €903; IQR = [823; 903]) in the AGA group.
The average costs by infant of all readmissions were
€1,229 (SD = €6,167, median = €0 IQR = [€0; €0]) and
€486 (SD = €3,245, median = €0 IQR = [€0; €0]) respect-
ively. The total average cost for infants was €4,178 (SD =
€10,711 median €1,205 IQR = [€903; €2,486]) in the SGA
group and €1,814 (SD = €4,996; median = €903; IQR
= [€903; €1,506]) in the AGA group. All cost differences
were significant (p < 0.001) (Table 4). Medians and IQR at
0 are explained by situations were more than 75% was not
hospitalized, and thus had a cost at 0.
Total cost
The total average cost for infants and mothers from
the beginning of pregnancy through the first year of
life was €2,783 higher in the SGA group than in the
AGA group: €7,609 (SD = €14,041, median = €4,213
IQR = [€2,252; €7,666]) and €4,826 (SD = €6,255, me-
dian = €3,070 IQR = [€1,817; €5,422]) in the SGA and
AGA groups respectively.
After stratifying newborns by gestational age, the
average total cost for infants was higher in the SGA group
than in the AGA group for all age groups. The highest
cost difference was found in the [32-37 [gestational age
group (N = 29,165 6%) (Fig. 3). The cost difference de-
creased with increasing gestational age (Fig. 3 and
Table 4).
The total cost of pre-and post-partum (1 year) hospital
admissions for SGA in France were €638 million. The
additional cost for SGA compared to AGA was €1,478
million of which one-third (€493 million) was spent on
preterm and two-thirds (€985 million) on full term
SGA infants.
The total cost from pregnancy through the first year of
life of all deliveries in France was €2,756 billion for
830,000 yearly births: SGA newborns represented 10.9%
of total deliveries and 23% of total costs.
Discussion
Main findings
While there is published evidence on the economic
consequences of preterm birth in several countries, the
impact of being small for gestational age has seldom
been assessed. Our main findings are that, of the total
779,376 births in France, the 84,688 SGA births cost on
average €7,609 per infant (median = €4,213) from preg-
nancy to 1 year of age, or €2,783 more in average than
AGA infants; SGA infants represented 23% of total
delivery costs.
Regardless of the term, compared to AGA infants,
SGA infants had longer hospital stays at delivery, were
more likely to be admitted to an intensive care unit and
were more likely to be hospitalised during the first year
of life, resulting in higher costs. The mothers of SGA
infants were also more likely to be hospitalised during
pregnancy and had longer delivery stays. Total costs
were highest for infants born between 22 to 28 weeks of
gestation, and excess costs were highest for infants born
between 32 to 37 weeks of gestation. After 37 weeks of
gestation, the cost difference decreased as the gesta-
tional age increased. By contrast, the excess mortality
increased when gestational age increased and was





Gestational age at delivery (weeks) N deaths % N N deaths % N
[22–28 [ 187 36.2 517 223 32.0 696
[28–32 [ 108 6.0 1,791 66 4.2 1,555
[32–37 [ 96 1.1 8,789 99 0.5 20,376
[37–39 [ 61 0.3 17,491 79 0.09 84,483
[39–43[ 77 0.1 56,100 161 0.06 288,650
TOTAL 529 0.6 84,688 628 0.16 395,760
SGA Small for Gestational Age; AGA Appropriate for Gestational Age
Fig. 2 Excess mortality for SGA infants compared to AGA infants by
to gestational age
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Table 4 Pregnancy to one year hospitalisation costs: mean (standard deviation), by gestational age for SGA and AGA infants
Gestational age
[22–28[ [28–32[ [32–37[ [37–39[ [39–43[
N = 1,213 N = 3,346 N = 29,165 N = 101,974 N = 344,750
SGA AGA SGA AGA SGA AGA SGA AGA SGA AGA
N = 517 N = 696 N = 1,791 N = 1,555 N = 8,789 N = 20,376 N= 17,491 N=84,483 N=56,100 N = 288,650




































































































































€ 4,725 € 5,814 € 6,757 € 1,952 € 561
Fig. 3 Hospital costs difference between SGA and AGA births according to gestational age
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higher in late preterm and term infants than in infants
at 28–36 weeks gestation.
Several reasons may explain this finding: the out-
come difference for pre-term births may be driven
mostly by gestational age rather than foetal growth,
thus reducing the relative effect of SGA. Additionally,
the absence of early diagnosis may have led to sub-
optimal obstetrical and neonatal management, which
in turn may have resulted in low costs but poor
outcome.
Strength and limitations
The strength of our study lies in the fact that we have an
exhaustive French hospital database with record linkage
over a 2-year period. Non-hospital births and births with
coding errors or imperfect linkage were excluded; the
initial dataset comprised 779,376 births of the 792,996
live births registered. Hospital costs were calculated ac-
cording to national French health insurance references.
We also included maternal costs, which are seldom re-
ported in perinatal economic studies.
Although the discharge database was initially devel-
oped as a tool for assessing funding related to medical
activities in public and private hospitals, the main
variables used in this study were recently found to be
robust when compared with national vital statistics data
[13] and to a national perinatal survey [10].
Furthermore, reporting of the variables in our study
(length of stay, intensive care utilisation, birth weight,
gestational age, mortality) are legally binding on hospitals
and subject to controls. We chose ‘hyper normal’ infants
for the comparator group but estimated the average neo-
natal cost for the population with the full dataset.
The main limitation was that our study considered only
hospital costs. Moreover, the 1-year time horizon is too short
to fully capture the economic consequences of SGA birth.
The long term health impacts have been documented, and
their costs will be assessed in future cohort studies.
Interpretation
Other studies of preterm infants compared to full term
infants found both higher mortality and complication
rates [17], higher service utilisation and costs [4, 8] and
an inverse relationship between gestational age and costs
[6–8, 16]. The total costs of preterm infants in our study
are comparable to those reported in countries with de-
veloped neonatal intensive care units [3, 4, 8, 9]. Full re-
suscitation is not standard in France before 24 weeks of
gestation; palliative care is provided to infants born earl-
ier. Thus costs in the 22–28 weeks gestational age group
may be even higher in countries were full resuscitation
is standard care. Lim found that on average the cost of
SGA infants was twice the cost of AGA infants [2]. This
cost difference is higher than in our study but used a dif-
ferent costing methodology. In contrast to the Canadian
study [2], we found that the difference between AGA
and SGA hospital costs was strongly related to gesta-
tional age, decreasing monotonously from 28 to 32 weeks
gestational age to term infants. The rates of caesarean
sections in both preterm and SGA in Canada were
markedly lower (6–13%) than in France [2, 18]. The
most recently published cost study of preterm infants in
the East Midlands reports birth to discharge hospital
costs comparable to ours, with the same association be-
tween costs and gestational age [6].
Conclusion
We found that being SGA predicted high hospital costs
regardless of gestational age. The additional cost of SGA
births was explained by higher complication rates, more
frequent hospital readmissions and longer lengths of stay.
SGA appears to be an independent contributor to high
hospital costs in the short term. This data could be used
in models to predict the costs associated with SGA [19].
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